Case report: Remdesivir induced dangerously low heart rate in a COVID-19 patient
Marmoset study identifies brain region linking actions to their outcomes
24 June 2021Uncovered: Crucial insight into how Ebola virus evades our immune defenses
24 June 2021Case report: Remdesivir induced dangerously low heart rate in a COVID-19 patient
After beginning treatment with remdesivir for COVID-19, a patient experienced significant bradycardia, or low heart rate. Her physicians used a dopamine infusion to stabilize her through the five-day course of remdesivir treatment, and her cardiac condition resolved itself at the end of the treatment. The case is discussed in Heart Rhythm Case Reports.
